DK103020C - Fremgangsmåde til fremstilling af derivater af 3-amino-2-oxazolidoner eller 3-amino-3,4,5,6-tetrahydrooxazinoner. - Google Patents

Fremgangsmåde til fremstilling af derivater af 3-amino-2-oxazolidoner eller 3-amino-3,4,5,6-tetrahydrooxazinoner.

Info

Publication number
DK103020C
DK103020C DK471862A DK471862A DK103020C DK 103020 C DK103020 C DK 103020C DK 471862 A DK471862 A DK 471862A DK 471862 A DK471862 A DK 471862A DK 103020 C DK103020 C DK 103020C
Authority
DK
Denmark
Prior art keywords
amino
tetrahydrooxazinones
oxazolidones
derivatives
preparation
Prior art date
Application number
DK471862A
Other languages
English (en)
Original Assignee
Abic Chemical Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Chemical Lab Ltd filed Critical Abic Chemical Lab Ltd
Application granted granted Critical
Publication of DK103020C publication Critical patent/DK103020C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D269/00Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
    • C07D269/02Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00 having the hetero atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK471862A 1961-11-02 1962-11-01 Fremgangsmåde til fremstilling af derivater af 3-amino-2-oxazolidoner eller 3-amino-3,4,5,6-tetrahydrooxazinoner. DK103020C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL1625661 1961-11-02

Publications (1)

Publication Number Publication Date
DK103020C true DK103020C (da) 1965-11-08

Family

ID=11043197

Family Applications (1)

Application Number Title Priority Date Filing Date
DK471862A DK103020C (da) 1961-11-02 1962-11-01 Fremgangsmåde til fremstilling af derivater af 3-amino-2-oxazolidoner eller 3-amino-3,4,5,6-tetrahydrooxazinoner.

Country Status (2)

Country Link
DE (1) DE1445406A1 (da)
DK (1) DK103020C (da)

Also Published As

Publication number Publication date
DE1445406A1 (de) 1969-02-27

Similar Documents

Publication Publication Date Title
DK115999B (da) Fremgangsmåde til fremstilling af 9,10-dihydro-ergovalin eller syreadditionssalte heraf.
DK104844C (da) Fremgangsmåde til fremstilling af 11,17-bis-oxygenerede-20-ketopregnan-21-glucuronider eller salte heraf.
DK115916B (da) Fremgangsmåde til fremstilling af 1-(2'-desoxy-D-ribofuranosyl)-5-fluor-cytosiner eller 4-N-p-toluoylderivater deraf.
DK116056B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-4,9-dien-3-oner eller deres D-homo-analoge.
DK108971C (da) Fremgangsmåde til fremstilling af 6,17α -dimethylprogesteronderivater.
DK112306B (da) Fremgangsmåde til fremstilling af 2,6-dichlor-toluenderivater.
DK105065C (da) Fremgangsmåde til fremstilling af 16α,17α-acetaler eller -ketaler af 3-oxo-16α,17α-dihydroxy-19-nor-4-pregnener eller 3-oxo-16α,17α-dihydroxy-19-nor-5(10)-pregnener.
DK103020C (da) Fremgangsmåde til fremstilling af derivater af 3-amino-2-oxazolidoner eller 3-amino-3,4,5,6-tetrahydrooxazinoner.
DK113857B (da) Fremgangsmåde til fremstilling af 16,17-acetaler eller -ketaler af mættede 16α, 17α-dihydroxy-3,20-diketo-5α-pregnan-derivater.
DK116280B (da) Fremgangsmåde til fremstilling af 4,5-dehydro-3-keto-19-nor-steroider.
DK114827B (da) Fremgangsmåde til fremstilling af 5-keto-11-hydroxy-17β-acyloxy-Δ<9>-des-A-estren eller 5,11-diketo-17β-acyloxy-Δ<9>-des-A-estren.
DK103239C (da) Fremgangsmåde til fremstilling af 2,3-dicyan-1,4-dithia-anthrahydroquinon eller 2,3-dicyan-1,4-dithia-anthraquinon.
DK111525B (da) Fremgangsmåde til fremstilling af monoalkylamino-propyliden-dibenzo-[b,e]-oksepin- eller -tiepinderivater eller deres hydrohalogenider.
DK99013C (da) Fremgangsmåde til fremstilling af 6,16-dimethyl-1,4,15-pregnatrienderivater.
DK98242C (da) Fremgangsmåde til fremstilling af 6,16-dimethyl-17α-hydroxy-3,20-diketo-4,6,15-pregnatrienderivater.
DK105033C (da) Fremgangsmåde til fremstilling af D-6-methyl- eller 1,6-dimethyl-8-aminomethylergolin-N-acylderivater.
DK102964C (da) Fremgangsmåde til fremstilling af 4-oxo-6-sulfamyl-1,2,3,4-tetrahyrdoquinazolinonderivater.
DK99142C (da) Fremgangsmåde til fremstilling af 6,16α-dialkyl-17α-hydroksy-6-dehydro-progesteron eller estere deraf.
DK105920C (da) Fremgangsmåde til fremstilling af 3-β-hydroxyethylimino-17 α-acyloxy-20-keto-4,6-pregnadien-(eller 1,4,6-pregnatrien)-derivater.
DK98959C (da) Fremgangsmåde til fremstilling af derivater af 5,6-dihydropyridoner.
DK101852C (da) Fremgangsmåde til fremstilling af derivater af 5,6-dihydro-pyridoner.
DK103076C (da) Fremgangsmåde til fremstilling af derivater af 5,6-dihydro-pyridoner.
DK98885C (da) Fremgangsmåde til fremstilling af 18,19-dinor-13-β-n-propyl-17α-ethinyl-testosteron.
DK97230C (da) Fremgangsmåde til fremstilling af S-oxider af iso-thionicotinamid eller derivater deraf.
DK100421C (da) Fremgangsmåde til fremstilling af 3,11,20-triketo-6-fluor-16α-methyl-21-hydroxy-Δ<4>-pregnen eller 21-estere deraf.